Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-300677
Filing Date
2025-11-26
Accepted
2025-11-26 16:37:03
Documents
1
Period of Report
2025-11-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3952
  Complete submission text file 0001193125-25-300677.txt   5392
Mailing Address C/O SANGAMO THERAPEUTICS, INC. 501 CANAL BLVD. RICHMOND CA 94084
Business Address
Meyers James R (Reporting) CIK: 0001387521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40407 | Film No.: 251530925

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)